Ovid Therapeutics Inc (OVID)

Jul 25, 2025

Ovid Therapeutics Inc. Stock Analysis and ForecastFree Market Dynamics Reports - PrintWeekIndia

Jul 25, 2025

Jul 25, 2025

Ovid Therapeutics Sells Ganaxolone Royalty Rights for $7M to Immedica Pharma - MSN

Jul 25, 2025

Jul 25, 2025

What drives Ovid Therapeutics Inc. stock priceConsistently profitable trades - PrintWeekIndia

Jul 25, 2025

Jul 24, 2025

Why Ovid Therapeutics Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser

Jul 24, 2025

Jul 24, 2025

Is Ovid Therapeutics Inc. a good long term investmentLightning-fast capital gains - Autocar Professional

Jul 24, 2025

Jul 24, 2025

Ovid Therapeutics shares rise 4.29% premarket after announcing participation in the BTIG Virtual Biotechnology Conference. - AInvest

Jul 24, 2025

Jul 23, 2025

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference - GlobeNewswire

Jul 23, 2025

Jul 23, 2025

12 Best Penny Stocks Under $1 to Buy Now - Insider Monkey

Jul 23, 2025

Jul 23, 2025

What analysts say about Ovid Therapeutics Inc. stockBreakout profit opportunities - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Ovid Therapeutics' Strategic Position in the Seizure and CNS Disorder Market: Pipeline Innovation and Partnership Potential - AInvest

Jul 23, 2025

Jul 23, 2025

Ovid Therapeutics to Participate in the BTIG Virtual Biotech Conference | OVID Stock News - GuruFocus

Jul 23, 2025

Jul 23, 2025

Brain Medicine Developer Ovid Therapeutics Reveals Latest Progress at Major BTIG Biotech Conference - Stock Titan

Jul 23, 2025

Jul 22, 2025

July 2025's Top Penny Stocks To Watch - simplywall.st

Jul 22, 2025

Jul 22, 2025

Ovid Therapeutics Stock Soars 13.88% on Investor Optimism - AInvest

Jul 22, 2025

Jul 19, 2025

Ovid Therapeutics (NASDAQ:OVID) Receives Average Rating of “Buy” from Analysts - Defense World

Jul 19, 2025

Jul 19, 2025

Ovid Therapeutics (NASDAQ:OVID) Stock Rating Upgraded by Wall Street Zen - Defense World

Jul 19, 2025

Jul 18, 2025

What makes Ovid Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - beatles.ru

Jul 18, 2025

Jul 17, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Jul 17, 2025

Jul 17, 2025

Ovid Therapeutics Surges 25% Amid Analyst Hype and Strategic Pipeline Progress - AInvest

Jul 17, 2025

Jul 16, 2025

Oliveda International, Inc. (OLVI) Announces Over 70% Growth in the First Half of 2025 - Yahoo.co

Jul 16, 2025

Jul 15, 2025

How Ovid Therapeutics Inc. stock performs during market volatilityTop Rated Trade Entries - Newser

Jul 15, 2025

Jul 15, 2025

Ovid Therapeutics (NASDAQ:OVID) Stock Price Down 2% – Time to Sell? - Defense World

Jul 15, 2025

Jul 11, 2025

Ovid Therapeutics Approves Key Proposals at Annual Meeting - The Globe and Mail

Jul 11, 2025

Jul 10, 2025

Local Bounti (LOCL) insider files Form 144 to sell 3,500 shares - Stock Titan

Jul 10, 2025

Jun 25, 2025

Ovid Therapeutics Sells Ganaxolone Royalties to Immedica - TipRanks

Jun 25, 2025